ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News– Researchers from Switzerland have announced the development of a gene-editing technique that may potentially aid in the treatment of Stargardt disease.
About Stargardt Disease
- It is a rare inherited genetic disorder that leads to progressive vision loss, especially in children and young adults.
- Cause: The disease is caused by mutations in the ABCA4 gene, which disrupts the body’s ability to process Vitamin A properly. This leads to the accumulation of lipofuscin, a fatty substance that builds up on the macula—the central part of the retina responsible for sharp, central vision.
- Bilateral: Stargardt disease typically affects both eyes (bilateral), resulting in the gradual loss of central visual acuity in both eyes.
- No Cure: There is currently no cure or effective treatment for Stargardt disease, though research continues to explore potential therapies.
